A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
3-Methylthiofentanyl
Voxilaprevir
Alectinib may decrease the excretion rate of Voxilaprevir which could result in a higher serum level.
3-Methylthiofentanyl
Abemaciclib
Alectinib may decrease the excretion rate of Abemaciclib which could result in a higher serum level.
3-Methylthiofentanyl
Ertugliflozin
Alectinib may decrease the excretion rate of Ertugliflozin which could result in a higher serum level.
3-Methylthiofentanyl
Talazoparib
Alectinib may decrease the excretion rate of Talazoparib which could result in a higher serum level.
3-Methylthiofentanyl
Velpatasvir
Alectinib may decrease the excretion rate of Velpatasvir which could result in a higher serum level.
3-Methylthiofentanyl
Darolutamide
Alectinib may decrease the excretion rate of Darolutamide which could result in a higher serum level.
3-Methylthiofentanyl
Glasdegib
Alectinib may decrease the excretion rate of Glasdegib which could result in a higher serum level.
3-Methylthiofentanyl
Delafloxacin
Alectinib may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
3-Methylthiofentanyl
Revefenacin
Alectinib may decrease the excretion rate of Revefenacin which could result in a higher serum level.
3-Methylthiofentanyl
Propacetamol
The serum concentration of Propacetamol can be increased when it is combined with Alectinib.
3-Methylthiofentanyl
Metreleptin
The metabolism of Alectinib can be increased when combined with Metreleptin.
3-Methylthiofentanyl
Armodafinil
The metabolism of Alectinib can be increased when combined with Armodafinil.
3-Methylthiofentanyl
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Alectinib.
3-Methylthiofentanyl
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Alectinib.
Phenazopyridine
Filgotinib
The serum concentration of Selexipag can be increased when it is combined with Filgotinib.
Phenazopyridine
Satralizumab
The serum concentration of Selexipag can be decreased when it is combined with Satralizumab.
Phenazopyridine
Abametapir
The serum concentration of Selexipag can be increased when it is combined with Abametapir.
Phenazopyridine
Selpercatinib
The serum concentration of Selexipag can be increased when it is combined with Selpercatinib.
Phenazopyridine
Tucatinib
Selexipag may decrease the excretion rate of Tucatinib which could result in a higher serum level.
Phenazopyridine
Mebutizide
The therapeutic efficacy of Selexipag can be increased when used in combination with Mebutizide.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3